Selinexor combined with bortezomib and dexamethasone is suitable for adult patients with multiple myeloma who have received at least one treatment in the past.
Selinexor is suitable for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including diffuse large B-cell lymphoma caused by follicular lymphoma that has undergone at least second-line systemic therapy.
from FDA,2022.07
How many generic drugs are there in Laos Lucius Selineso?This study aims to dete···【more】
Release date:2024-11-26Recommended:121